Acute antidepressant effects of intramuscular versus intravenous ketamine

Indian Journal of Psychological Medicine

Volumn 36, Issue 1, 2014, Pages 71-76

  Chilukuri, Harihar ^a   Reddy, Narasimha ^b   Pathapati, Ram ^b   Manu, Arkalgud ^b   Jollu, Sharada ^b   Shaik, Ahammed ^b  

^a Malla Reddy Institute of Medical Sciences   (India)

^b NARAYANA MEDICAL COLLEGE   (India)

Author keywords

Acute antidepressant effects; antidepressant drugs; depression; intramuscular ketamine; intravenous ketamine; suicidal risk

Indexed keywords

EID: 84894730497     PISSN: 02537176     EISSN: 09751564     Source Type: Journal    
DOI: 10.4103/0253-7176.127258     Document Type: Article

References (22)

1. Winstock AR, Schifano F. Disorders relating to the use of ecstasy and other 'party drugs'. In: Gelder MG, Andreasen NC, lopez-Ibor JJ Jr, Geddes JR, editors. New Oxford Textbook of Psychiatry, 2nd ed, New York: Oxford University Press Inc.; 2011. p. 499-501.
2. Tizabi Y, Bhatti BH, Manaye KF, Das JR, Akinfiresoye L. Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats. Neuroscience 2012;28:72-80.
3. Rao TS, Andrade C. Innovative approaches to treatmentrefractory depression: The ketamine story. Indian J Psychiatry 2010;52:97-9.
4. Liebrenz M, Borgeat A, Leisinger R, Stohler R. Intravenous Ketamine therapy in a patient with a treatmentresistant major depression. Swiss Med Wkly 2007;137:234-6.
5. Sivagnanam G. Chronotherapy in hypertension. J Pharmacol Pharmacother 2012;3:209.
6. Thangathurai D, Mogos M. Ketamine alleviates fear, depression, and suicidal ideation in terminally ill patients. J Palliat Med 2011;14:389.
7. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of Ketamine in depressed patients. Biol Psychiatry 2000;47:351-4.
8. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006;63:856-64.
9. Price RB, Nock MK, Charney DS, Mathew SJ. Effects of intravenous Ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 2009;66:522-6.
10. DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 2010;71:1605-11.
11. Thakurta RG, Ray P, Kanji D, Das R, Bisui B, Singh OP. Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression? Indian J Psychol Med 2012;34:56-60.
12. Zanicotti CG, Perez D, Glue P. Mood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancer. J Palliat Med 2012;15:400-3.
13. Harihar C, Dasari P, Srinivas JS. Intramuscular ketamine in acute depression: A report on two cases. Indian J Psychiatry 2013;55:186-8.
14. Irwin SA, Iglewicz A. Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care. J Palliat Med 2010;13:903-8.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
16. Attention deficit hyperactivity disorder and sleep. Insomnia and other sleep problems may worsen symptoms of ADHD; treatment options exist. Harv Ment Health Lett 2010;27:6-7.
17. Sanacora G. Ketamine-Induced Optimism: New Hope for the Development of Rapid-Acting Antidepressants. Psychiatric Times 2012;29(July):1-2.
18. Murrough JW, Charney DS. Cracking the moody brain: Lifting the mood with ketamine. Nat Med 2010;16:1384-5.
19. Roca CP, Lozano S, Arenas A, Sánchez A. Topological traps control flow on real networks: The case of coordination failures. PLoS One 2010;5:e15210.
20. Garcia LS, Comim CM, Valvassori SS, Réus GZ, Andreazza AC, Stertz L, et al. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol 2008;103:502-6.
21. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011;475:91-5.
22. Machado-Vieira R, Yuan P, Brutsche N, DiazGranados N, Luckenbaugh D, Manji HK, et al. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist. J Clin Psychiatry 2009;70:1662-6.